FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

16554311000001100: Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) 28 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Feb 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
293771000001112 Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57927101000001111 Memantine 20mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) 28 tablet (product) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) 28 tablet (product) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) 28 tablet (product) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) 28 tablet (product) Is a Memantine 20mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) 28 tablet (product) Has AMP Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) (product) true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) 28 tablet (product) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) 28 tablet (product) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) 28 tablet (product) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) 28 tablet (product) Has specific active ingredient Memantine hydrochloride true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) 28 tablet (product) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) 28 tablet (product) Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) 28 tablet (product) Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) 28 tablet (product) Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Memantine 20mg tablets (PI) (Mawdsley-Brooks & Company Ltd) 28 tablet (product) Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start